We found that the levels of mRNA expression of PAFAH1B3 were increased in HCC cell lines, especially in HepG2, compared with the LO2 liver cell line (p < 0.001) (Figure 4A). This evidence concerns the gene PAFAH1B3 and hepatocellular carcinoma.